Ohcanbohtosat - Wesseling, Jelle
- Čájehuvvo 1 - 20 / 73
- Sirdás čuovvovaš siidui
-
1
A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samples Dahkki Zwart, Wilbert, Koornstra, Rutger, Wesseling, Jelle, Rutgers, Emiel, Linn, Sabine, Carroll, Jason S
Almmustuhtton 2013Teaksta -
2
-
3
-
4
-
5
Pathological and Biological Differences Between Screen-Detected and Interval Ductal Carcinoma in situ of the Breast Dahkki de Roos, Marnix A., van der Vegt, Bert, de Vries, Jaap, Wesseling, Jelle, de Bock, Geertruida H.
Almmustuhtton 2007Teaksta -
6
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based... Dahkki Elshof, Lotte E., Schaapveld, Michael, Schmidt, Marjanka K., Rutgers, Emiel J., van Leeuwen, Flora E., Wesseling, Jelle
Almmustuhtton 2016Teaksta -
7
Erratum to: Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a popu... Dahkki Elshof, Lotte E., Schaapveld, Michael, Schmidt, Marjanka K., Rutgers, Emiel J., van Leeuwen, Flora E., Wesseling, Jelle
Almmustuhtton 2016Teaksta -
8
Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ Dahkki Elshof, Lotte E., Schmidt, Marjanka K., Rutgers, Emiel J.Th., van Leeuwen, Flora E., Wesseling, Jelle, Schaapveld, Michael
Almmustuhtton 2018Teaksta -
9
Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping Dahkki Rontogianni, Stamatia, Synadaki, Eleni, Li, Bohui, Liefaard, Marte C., Lips, Esther H., Wesseling, Jelle, Wu, Wei, Altelaar, Maarten
Almmustuhtton 2019Teaksta -
10
-
11
The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study Dahkki Elshof, Lotte E., Schaapveld, Michael, Rutgers, Emiel J., Schmidt, Marjanka K., de Munck, Linda, van Leeuwen, Flora E., Wesseling, Jelle
Almmustuhtton 2017Teaksta -
12
Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice Dahkki Derksen, Patrick W. B., Braumuller, Tanya M., van der Burg, Eline, Hornsveld, Marten, Mesman, Elly, Wesseling, Jelle, Krimpenfort, Paul, Jonkers, Jos
Almmustuhtton 2011Teaksta -
13
PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy Dahkki Beelen, Karin, Hoefnagel, Laurien DC, Opdam, Mark, Wesseling, Jelle, Sanders, J, Vincent, Andrew D, van Diest, Paul J, Linn, Sabine C
Almmustuhtton 2014Teaksta -
14
Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot Dahkki Beelen, Karin, Opdam, Mark, Severson, Tesa, Koornstra, Rutger, Vincent, Andrew, Wesseling, Jelle, Sanders, Joyce, Vermorken, Jan, van Diest, Paul, Linn, Sabine
Almmustuhtton 2018Teaksta -
15
Effect of bile absorption coefficients on the estimation of liver tissue optical properties and related implications in discriminating healthy and tumorous samples Dahkki Nachabé, Rami, Evers, Daniel J., Hendriks, Benno H. W., Lucassen, Gerald W., van der Voort, Marjolein, Wesseling, Jelle, Ruers, Theo J. M.
Almmustuhtton 2011Teaksta -
16
Lack of Genomic Heterogeneity at High-Resolution aCGH between Primary Breast Cancers and Their Paired Lymph Node Metastases Dahkki Vollebergh, Marieke A., Klijn, Christiaan, Schouten, Philip C., Wesseling, Jelle, Israeli, Danielle, Ylstra, Bauke, Wessels, Lodewyk F.A., Jonkers, Jos, Linn, Sabine C.
Almmustuhtton 2014Teaksta -
17
Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer Dahkki Loo, Claudette E., Rigter, Lisanne S., Pengel, Kenneth E., Wesseling, Jelle, Rodenhuis, Sjoerd, Peeters, Marie-Jeanne T. F. D. Vrancken, Sikorska, Karolina, Gilhuijs, Kenneth G. A.
Almmustuhtton 2016Teaksta -
18
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer Dahkki Lips, Esther H., Benard-Slagter, Anne, Opdam, Mark, Scheerman, Caroline E., Wesseling, Jelle, Hogervorst, Frans B. L., Linn, Sabine C., Savola, Suvi, Nederlof, Petra M.
Almmustuhtton 2020Teaksta -
19
Non-invasive longitudinal imaging of tumor progression using an (111)indium labeled CXCR4 peptide antagonist Dahkki Buckle, Tessa, van Berg, Nynke S, Kuil, Joeri, Bunschoten, Anton, Oldenburg, Joppe, Borowsky, Alexander D, Wesseling, Jelle, Masada, Ryo, Oishi, Shinya, Fujii, Nobutaka, van Leeuwen, Fijs WB
Almmustuhtton 2011Teaksta -
20
Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness Dahkki Lips, Esther H, Laddach, Nadja, Savola, Suvi P, Vollebergh, Marieke A, Oonk, Anne MM, Imholz, Alex LT, Wessels, Lodewyk FA, Wesseling, Jelle, Nederlof, Petra M, Rodenhuis, Sjoerd
Almmustuhtton 2011Teaksta